By David Bautz, PhD NASDAQ: FBLG READ THE FULL FBLG RESEARCH REPORT Business Update Advancing Fibroblast Therapy on Multiple Fronts In the past month, FibroBiologics, Inc. (NASDAQ: FBLG) has disclosed ...

Researchers identified BCL-2 as a key factor allowing fibroblasts to evade cell death and drive pulmonary fibrosis.

A team of University at Buffalo researchers has developed a new strontium-loaded scaffold that can be personalized to fit any size dental implant and could help improve healing and tissue attachment ...

Regular erections could be important for maintaining erectile function, according to a new study on mice published in Science by researchers at Karolinska Institutet. “We discovered that an increased ...

Association of genomic alterations in circulating tumor DNA (ctDNA) with clinical response to telisotuzumab vedotin (Teliso-V) in 2L+ EGFR wildtype (EGFRwt) non-squamous non-small cell lung cancer ...

More than 10,000 Americans are waiting for a liver transplant. Many more never make the list, because they are too sick to handle a major surgery. That gap is why an idea that sounds a little strange ...